Atlanta biologicals, INC. [12-005213]

Ended Awarded

Contract number
HHSN26100005
Awardee
Awarding agency
Obligated
$24,984

Award facts

Contract value 100% obligated
$24,984.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Lawrenceville, GA 30043, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This is a firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Cancer Institute, a civilian agency, to Atlanta Biologicals Incorporated. The contract, valued at $24,984.00, was awarded on November 2, 2011 with a completion date of November 30, 2011. The contract does not have a set-aside designation. As a BPA call, this award is likely part of a larger contract vehicle managed by the National Cancer Institute to acquire biologics and related supplies in support of the agency's biomedical research programs.

Quick answers

Who was awarded contract HHSN26100005?

HHSN26100005 was awarded to Atlanta Biologicals Incorporated by National Cancer Institute (National Institutes of Health) on November 2, 2011.

How much is contract HHSN26100005 worth?

The government has obligated $24,984 on HHSN26100005.

Is contract HHSN26100005 an order under another contract?

Yes. HHSN26100005 is a BPA call under HHSN263200600063475B, a blanket purchase agreement.

Was contract HHSN26100005 competed?

The extent of competition for HHSN26100005 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login